InvestorsHub Logo
Followers 27
Posts 2742
Boards Moderated 0
Alias Born 03/17/2017

Re: None

Monday, 05/15/2017 4:36:44 AM

Monday, May 15, 2017 4:36:44 AM

Post# of 13
copied from stockhouse:

Stock price lost like 3x -20% the dilution 7%,
probably anticipating ongoing OS increase - of course, OS:

- 2016-03-31 58.47M
- 2016-12-31 81.66M
- 2017-03-31 87.93M

mcap
- 2016-03-31 $10.23M @ $0.175/sh - $14.62M @ $0.25/sh
- 2016-12-29 $24.49M @ $0.300/sh
- 2017-05-12 $20.66M @ $0.235/sh

Revenue is only about $1M per anno at a loss,
hence P/S 10 - 25 is given here, quite biggly.

A P/S 4 would lead to $4M mcap -> $0.045/sh only.

AFAIK company needs to hurry up big time to preserve the dream
of a big growth biotech - NOW.
Evaluations are surely overstretched at this point,
where our high expectations were disapointed.

JMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GEN News